Federated Hermes’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-321,477
Closed -$2.09M 2156
2023
Q4
$2.09M Buy
+321,477
New +$2.07M 0.01% 939
2022
Q3
Sell
-1,461
Closed -$22K 2264
2022
Q2
$22K Sell
1,461
-1,186
-45% -$17.5K ﹤0.01% 1759
2022
Q1
$54K Sell
2,647
-117,431
-98% -$2.39M ﹤0.01% 1730
2021
Q4
$3.5M Sell
120,078
-25,160
-17% -$720K 0.01% 918
2021
Q3
$3.13M Buy
145,238
+1,003
+0.7% +$24.2K 0.01% 934
2021
Q2
$3.7M Buy
144,235
+11,844
+9% +$253K 0.01% 918
2021
Q1
$2.41M Buy
132,391
+129,126
+3,955% +$2.15M ﹤0.01% 1045
2020
Q4
$38K Buy
+3,265
New +$29.8K ﹤0.01% 1847

Other funds holding CDMO

Federated Hermes's CDMO Position: Q1 2024 in Review

Federated Hermes sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2024, closing a stake of 321,477 shares — an estimated $2.09M sold.

Federated Hermes first reported a position in CDMO in Q4 2020 and held it in 8 quarters. The position peaked at $3.7M in Q2 2021. 166 funds tracked by Wall St. Rank hold CDMO as of Q1 2024.

  • Federated Hermes reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Federated Hermes sold 321,477 Avid Bioservices, Inc. Common Stock shares in Q1 2024, an estimated $2.09M.
  • Federated Hermes first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
  • Federated Hermes's Avid Bioservices, Inc. Common Stock position peaked at $3.7M in Q2 2021.
  • 166 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2024.

Based on Federated Hermes's 13F filing for Q1 2024, filed 14 May 2024.